Research Fellows

Dr Rory Casey

Casey received his PhD in Molecular Biology from Trinity College Dublin in 2011, and subsequently was appointed a postdoctoral researcher within Trinity College to investigate the properties of a novel anti-angiogenic compound in metastatic colorectal cancer. Dr Casey joined OncoMark Ltd in 2013 as a postdoctoral researcher within the FP7-funded AngioPredict and APO-DECIDE projects. He was then seconded to University College Dublin in 2015 under FAST-PATH to generate a novel fluorescence-based detection and quantitation system for analysing prostate cancer biomarkers.

Dr Priya Lakshmi Narayan

Dr Priya Lakshmi Narayan received her PhD degree in Biomedical Engineering for her work in developing an atlas of cerebellum for young children. She worked as a research scholar in MRC/UCT Medical Imaging Research Unit, University of Cape Town, South Africa from 2010 - 2013. She has also worked as a visiting academic in Athinoula A. Martinos center for Biomedical Imaging in Boston from July 2012 – December 2012. 

She has gained a considerable amount of experience working as an image analyst during her tenure at Optra Systems, Pune, India after completing her Masters in 2007 from Madras Institute of Technology, Anna University, India. During her tenure she contributed to the detection of lumen in prostate cancer and micro array analysis for single cell detection using segmentation methods and classification using neural networks. She was recruited to PathXL in 2014 under the FAST-PATH project.

Dr Nicholas McCarthy 

                                                                                                                                          Dr McCarthy holds a degree in Computer Science from University College Dublin and was awarded his PhD by UCD in 2015. His research interests centre on implementing novel methods, improving accuracy and practical applications for a computer-aided diagnosis system for prostate carcinoma.  Mr McCarthy joined the FAST-PATH project at the beginning of 2014 as a Junior research fellow within PathXL.

Dr Patrick Jackman

Dr Jackman was awarded his PhD in Biosystems Engineering in 2009, following receipt of his Masters in 2005 and his Bachelor degree in Chemical Engineering in 2001, all from University College, Dublin. 
Patrick's previous projects centred on food related research, incorporating his expertise in image processing, segmentation and quantification along with complex data analysis and interpretation. He joined the FAST-PATH project in October 2014, under the mentorship of Professor Watson at UCD's Conway Institute.

Dr Agnieszka Krzyzanowska

Agnieszka Krzyzanowska was awarded a BSc in Human Sciences and an MSc in Neuroscience from University College London, followed by a PhD in Neuroscience from King's College London. From 2007 until 2014 she worked as a postdoctoral fellow in Madrid, Spain, first in stereology and histology of peripheral nerves at the Autonoma University, followed by a project involving biomarkers in Alzheimer’s disease at the Hospital 12 de Octubre research centre. 

Her areas of expertise are histology, tissue processing, immunohistochemistry, microscopy and image analysis, as well as cellular and molecular biology. Agnieszka joined Lund University as part of the FAST-PATH project in April 2014. She is working on the optimization of Time Resolved Fluorescence Imaging (TRFI) for the detection and quantification of biomarkers in prostate cancer tissue.

Dr Giuseppe Lippolis

Giuseppe Lippolis was awarded a Bachelor in Biomedical Engineering from the Politecnico di Milano, Italy in 2005, and subsequently completed an MSc in Biomedical Engineering in Lund University, Sweden in 2009. Giuseppe completed his PhD in the Center for Molecular Pathology in Lund University in 2015; his PhD research focused on prostate cancer and the development of high-throughput systems for tissue biomarker analysis. Giuseppe was seconded to PathXL as part of the FAST-PATH programme, where he further developed the use of Time Resolved Fluorescence Imaging (an attractive alternative to standard immunohistochemistry) to quantify prostate cancer biomarkers in clinical samples.

Dr Maria Prencipe 

Dr Maria Prencipe was awarded her Degree in Biological Sciences in 1999 followed by a Master's degree in Biochemistry and Molecular Biology in 2001 from L’Aquila University, Italy. After 3 years as a research assistant in the research hospital “Casa Sollievo della Sofferenza”, San Giovanni Rotondo, Italy, she moved to Ireland where she was awarded her PhD in Cancer Biology from University College Dublin, studying the mechanisms of resistance to taxane treatment in breast and ovarian cancer. As a postdoctoral fellow within Molecular Therapeutic for Cancer Ireland (MTCI) research cluster, she studied the molecular mechanisms of resistance to advanced prostate cancer treatments, identifying novel transcription factors as potential new therapies for advanced prostate cancer. She was awarded an Irish Cancer Society research fellowship in 2012 to carry on her work on transcription factors’ role in prostate cancer. She was seconded to OncoMark Ltd to work on the FAST-PATH project.

Dr Jesuchristopher Joseph 
Dr Jesuchristopher Joseph obtained his PhD in the field of Medical Image Processing from Anna University, Chennai, India in 2008. He then worked as a postdoctoral fellow in MRC/UCT Medical Imaging Research Unit, University of Cape Town, South Africa, developing a novel 3D surface deformation-based shape analysis method to assess the shape variations of subcortical structures. He also worked in the area of medical microscopic image processing in Optra Systems Pvt. Ltd., and developed various applications for medical image segmentation and quantification. He has over six years of experience in the fields of medical image processing. The projects he has worked on so far include: automated segmentation of glomerular tuft region; automated segmentation of lumen in prostate cancer using pattern recognition approach; computerised analysis of structural and functional evaluation of spermatozoa; content based image retrieval system for medical images and facial recognition system using a neural network based technique. Dr Joseph joined OncoMark Ltd in December 2012 as part of the FAST-PATH team and brought to the company his technical expertise in image analysis, namely, in developing the image processing applications for medical images (segmentation, registration, pattern recognition), machine vision (target detection, motion tracking) and advanced graphical user interfaces.

Dr Piotr Bański 

Dr Ba
ński was awarded his PhD by McGill University, Canada, in 2011, following an MSc in Molecular Biology and a Bachelor's degree in Biology from the Université du Québec a Montréal. Dr Bański's PhD focused on the nucleolar accumulation of hsc70, and during this time he gained considerable experience in molecular biology and cell biology techniques. Dr Bański joined Uppsala University and the associated Human Protein Atlas Project in Sweden, in May 2013 and worked on the identification of novel biomarkers for prostate cancer during his time as an experienced researcher within the FAST-PATH programme.   

Dr Peter Bankhead
Dr Bankhead was awarded both an MSc in Computer Science and PhD in biomedical image analysis from Queen's University Belfast. Dr Bankhead's PhD project investigated retinal blood flow by optimising the rapid detection and measurement of calcium signalling and blood vessels in the retina. Following his PhD, Dr Bankhead worked in the Nikon Imaging Centre in Heidelberg, Germany, where he contributed to a wide range of biology-based imaging research projects, before re-joining Queen's University Belfast as a FAST-PATH research fellow. Dr Bankhead's role in FAST-PATH was to develop high performance computing solutions for the analysis of prostate cancer samples.       

Dr Yinhai Wang
Dr Yinhai Wang is an experienced researcher in Digital Pathology and has been working in this field since 2005. Dr Wang focuses on tissue-based research and development using mainly novel machine vision and image processing techniques for tissue diagnosis, the identification of novel biomarkers for companion diagnostics, prognostics and for predicting response to therapy in cancer. Some of Dr Wang's recent work includes the integration of digital pathology into research and clinical workflows, high performance tissue computation and novel human-tissue viewing interfaces. Dr Wang previously worked in the computer science and electronic engineering industry for 4 years carrying out research and development in DSPs, biometrics and CCTVs. Under the FAST-PATH programme, Dr Wang spent 12 months working in PathXL Ltd in Belfast, on secondment from Queen's University Belfast, and was then seconded to OncoMark Ltd for 9 months. 

Dr Gillian O’Hurley
Dr O’Hurley achieved a Double Honours Degree in Biology and Statistics and a Masters Degree in Immunology and Global Health from NUI Maynooth in 2006 and 2007 respectively. She was successful in obtaining an Irish Cancer Society PhD scholarship in September 2007, which she completed in August 2011, under the supervision of Professor Elaine Kay in the field of pathology working on histological evaluation of novel biomarkers in prostate cancer.  Following this, Dr O’Hurley was appointed by OncoMark Ltd where she worked on a European Framework 7 funded project entitled ”RATHER”, which focused on providing new rationalised therapy options for difficult-to-treat breast cancer subtypes. Dr O’Hurley joined Uppsala University in Sweden in August 2012 where she worked as a Marie Curie post-doctoral fellow on the FAST-PATH program within the Human Protein Atlas project under the supervision of Professor Fredrik Pontén.  Her project was entitled ”Evaluation of novel protein-protein interactions with the Androgen receptor in Androgen independent prostate cancer via the use of PLA technology”. Dr O'Hurley was then seconded to University College Dublin in 2013 where she focused on the identification and validation of novel prostate cancer biomarkers within the FAST-PATH programme. 

Dr Dara Fitzgerald

Dr Dara FitzGerald gained his BSc in Computer Science and Biology in 1992 and PhD in Image Analysis in Biotechnology in 1996. He set up and ran an Image Analysis Research Group in University College Dublin from 1996-2000, where he was involved in developing Image Analysis solutions for medical, veterinary and food technology academic and industrial research. He co-founded and was MD for Bio Observation Systems (PixAlert) an image analysis solutions company. In 2005 he left BOS (PixAlert) and set up Citrus Fields Consulting, providing image analysis and business development solutions. In 2007 he was approached by the Irish Government (Enterprise Ireland) to be placed within the US National Institutes of Health, and interact with other US Federal agencies as US Federal Liaison on a 2 year contract. In 2009 he joined the National Digital Research Centre in Dublin, to support business development for a number of emerging technology-based businesses. In 2010 he joined OncoMark Ltd, a cancer diagnostics company, as CEO. In early 2012 Dr FitzGerald took on a brief secondment to University College Dublin as a Marie Curie more experienced researcher to support technology and business development for UCD-CBT technology, and develop his personal skills, under the FAST-PATH EU FP7 project.